Page last updated: 2024-09-03
2-pyrrolino-dox and daunosamine
2-pyrrolino-dox has been researched along with daunosamine in 1 studies
Compound Research Comparison
Studies (2-pyrrolino-dox) | Trials (2-pyrrolino-dox) | Recent Studies (post-2010) (2-pyrrolino-dox) | Studies (daunosamine) | Trials (daunosamine) | Recent Studies (post-2010) (daunosamine) |
---|---|---|---|---|---|
28 | 0 | 2 | 32 | 0 | 5 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Brabec, V; Kasparkova, J; Liskova, B; Malina, J; Novakova, O; Stepankova, J; Studenovsky, M; Ulbrich, K | 1 |
Other Studies
1 other study(ies) available for 2-pyrrolino-dox and daunosamine
Article | Year |
---|---|
DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin.
Topics: Animals; Antineoplastic Agents; Cell-Free System; DNA; DNA Adducts; DNA Topoisomerases, Type II; Doxorubicin; Gene Expression Regulation, Neoplastic; Hexosamines; Humans; Mice; Molecular Structure; Pyrroles; Topoisomerase II Inhibitors; Transcription, Genetic | 2011 |